Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2025-12-24 @ 9:57 PM
NCT ID:
NCT06205732
Eligibility Criteria:
Inclusion Criteria:
* ≥18 years old, both men and women
* primary liver cancer confirmed by liver biopsy or history of hepatitis B, AFP, and typical imaging findings
* patients with liver function Child-Pugh A or B (≤8 points)
* BCLC stage B and stage C
* expected survival time ≥8 weeks
* patients with generally good performance status (ECOG PS score 0 or 1)
Exclusion Criteria:
* The patient's key data is missing
* liver metastatic cancer confirmed by histology or cytology
* patients who interrupt treatment due to intolerance of adverse drug reactions
* combined with primary malignant tumors of other organs within 5 years; combined with other serious diseases, such as severe heart disease, renal insufficiency, severe infection, bleeding, etc.
* combined with systemic infection, autoimmune disease, or other types of tumors; previous allogeneic bone marrow transplantation or solid organ transplantation
* study participants known to have mental illness
* situations such as drug use or substance abuse
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06205732
Study Brief:
Protocol Section:
NCT06205732